# 名词简称

| 简称     | 全称                                    | 翻译         |
| ------ | ------------------------------------- | ---------- |
| DN/DMN | Default Mode Network                  | 默认模式网络     |
| SN     | salience network                      | 突显网络       |
| ICNs   | Intrinsic Connectivity Network        | 固有连接网络     |
| ICA    | Independent Component Analysis        | 独立成分分析     |
| OGM    | overgeneral autobiographical memory   | 过度概括的自传体记忆 |
| rsFC   | resting-state functional connectivity | 静息态功能连接    |
| FN/FPN | frontoparietal network                | 额顶网络       |
| CEN    | central executive network             | 中央执行网络     |
| DAN    | dorsal attention network              | 背侧注意网络     |
| AN     | affective network                     | 情感网络       |
| VAN    | ventral attention network             | 腹侧注意网络     |
| CT     | cortical thickness                    |            |
| SA     | surface area                          |            |
| CV     | cortical volume                       |            |
| LGI    | local gyrification index              | 局部褶皱化指数    |
| GMV    | gray matter volume                    |            |



Brain-based Sex Differences in Depression: A Systematic Review of Neuroimaging Studies
https://doi.org/10.1007/s11682-023-00772-8

没有纳入多站点研究

| 研究                             | 研究设计 | 研究组别                         | 样本量 (女/男)         | 年龄 (岁) (平均±标准差)                                         | MRI/DTI/fMRI | 抑郁症测量工具                          | 药物治疗                               | 匹配变量         |
| ------------------------------ | ---- | ---------------------------- | ----------------- | ------------------------------------------------------- | ------------ | -------------------------------- | ---------------------------------- | ------------ |
| Amiri et al., 2021             | 病例对照 | 难治性抑郁症 (TRD) 健康对照组 (HC)      | 21/10 18/11       | 35.7±9.1 31.7±6.1                                       | fMRI         | HAMD-17                          | 未报告 (NR)                           | 未报告 (NR)     |
| Ancelin et al., 2019           | 病例对照 | 终生MDD 无终生MDD                 | 320/290 (总)       | 70.7 (中位数)                                              | MRI          | DSM-IV MINI                      | 抗抑郁药                               | 未报告 (NR)     |
| Briceño et al., 2015           | 病例对照 | MDD HC                       | 27/26 31/26       | 46.1 (平均) 44.1 (平均)                                     | fMRI         | DSM-IV HDRS                      | 未报告 (NR)                           | 年龄，性别        |
| Carceller-Sindreu et al., 2015 | 病例对照 | 首发MDD 缓解-复发MDD               | 14/7 18/2         | 44.4±6.7 47.1±8.2                                       | MRI          | DSM-IV-TR HDRS                   | 精神药物                               | 年龄，性别分布，教育水平 |
|                                |      | 慢性MDD HC                     | 16/4 24/10        | 48.6±8.0 47.9±8.1                                       |              |                                  |                                    |              |
| Chuang et al., 2017            | 病例对照 | MDD HC                       | 82/24 24/10       | 女: 15.72±1.10 男: 15.25±1.52 女: 15.89±1.42 男: 15.26±1.22 | fMRI         | DSM-IV                           | 抗抑郁药                               | 年龄，性别，用手习惯   |
| Cyprien et al., 2014           | 队列研究 | 晚年抑郁症 (LLD) 非LLD             | 75/45 137/210     | 70.8±4.0 71.1±4.0                                       | MRI          | MINI CESD-                       | 抗抑郁药，抗高血压药                         | 药物服用         |
| De Almeida et al., 2011        | 病例对照 | MDD HC                       | 12/7 12/7         | 30.3±7 31.8±6.8                                         | fMRI         | HDRS                             | 抗抑郁药，情绪稳定剂，抗精神病药，抗焦虑药              | 年龄，性别        |
| Dong et al., 2022              | 病例对照 | MDD HC                       | 76/48 137/106     | 女: 25.68±7.90 男: 24.75±5.16 女: 21.33±4.28 男: 20.54±2.13 | fMRI         | DSM-IV-TR HAMD-17                | 无                                  | 性别           |
| Furtado et al., 2008           | 病例对照 | TRD HC                       | 23/22 17/13       | 37.53±11.3 36.6±11.09                                   | MRI          | DSM-IV MINI HDRS                 | 抗抑郁药 (TCA, NaSSA, NRI, RIMA, SNRI) | 年龄，性别        |
| Geng et al., 2019              | 病例对照 | 躯体化抑郁症 (SD) 非躯体化抑郁症 (NSD) HC | 15/13 16/14 13/17 | 37.21±7.16 34.10±9.91 35.83±8.15                        | fMRI         | DSM-IV MINI HAMD-17              | 抗抑郁药 (SSRI, SNRI, NaSSA, 苯二氮卓类)    | 年龄，教育，性别     |
| Hastings et al., 2004          | 病例对照 | MDD HC                       | 10/8 10/8         | 38.9±11.4 34.8±13.6                                     | MRI          | DSM-III-R SCID-P SCID-NP         | 无                                  | 性别           |
| Ho et al., 2021                | 病例对照 | MDD HC                       | 34/14 19/16       | 16.32±1.19 15.75±1.22                                   | DTI          | DSM-IV K-SADS-PL RADS-2          | 精神药物                               | 未报告 (NR)     |
| Jenkins et al., 2018           | 病例对照 | MDD HC                       | 32/16 25/15       | 女: 21.72±1.28 男: 20.69±1.62 女: 21.00±1.63 男: 20.67±1.76 | fMRI         | DSM-IV-TR                        | 无                                  | 性别           |
| Kliamovich et al., 2021        | 队列研究 | MDD HC                       | 39/24 184/215     | 14.88±1.44 14.87±1.78                                   | DTI          | DSM-IV SSAGA                     | 无                                  | 未报告 (NR)     |
| Kong et al., 2013              | 病例对照 | MDD HC                       | 16/13 17/16       | 女: 28.88±9.71 男: 31.23±8.39 女: 28.00±9.09 男: 31.81±7.05 | MRI          | DSM-IV HAMD                      | 无                                  | 年龄，教育        |
| Kronmuller et al., 2009        | 病例对照 | 首发MDD 缓解MDD                  | 未报告 (NR)          | 未报告 (NR)                                                | MRI          | DSM-IV SCID HDRS                 | 无                                  | 年龄，性别        |
|                                |      | HC                           | 未报告 (NR)          | 未报告 (NR)                                                |              |                                  |                                    |              |
| Lavretsky et al., 1998         | 病例对照 | 早发MDD 晚发MDD                  | 10/10 10/10       | 24.3±1.2 72.8±1.3                                       | MRI          | DSM-III-R                        | 无                                  | 未报告 (NR)     |
| Lewine et al., 1995            | 病例对照 | MDD 精神分裂症                    | 12/12 12/12       | 30.6±11.4 28.3±9.4                                      | MRI          | DSM-III-R                        | 未报告 (NR)                           | 年龄，用手习惯      |
| MacMaster et al., 2006         | 病例对照 | MDD HC                       | 10/9 10/9         | 11.2±1.5 11.0±1.5                                       | MRI          | DSM-IV CDRS-R                    | 无                                  | 年龄，ICV       |
| Mei et al., 2022               | 病例对照 | MDD HC                       | 45/45 45/45       | 33.3±11.5 34.0±12.4                                     | fMRI         | DSM-IV-TR HAMD-17                | 无                                  | 年龄，教育，性别     |
| Nielsen et al., 2020           | 纵向队列 | MDD HC                       | 88/47 101/45      | 13.9±0.6 13.9±0.6                                       | MRI          | DSM-IV CDI                       | 1名参与者服用                            | 年龄，母亲抑郁史     |
| Piani et al., 2021             | 病例对照 | MDD HC                       | 20/20 20/20       | 24.1±3.1 24.5±2.2                                       | MRI, fMRI    | DSM-5 HAMD-17 DASS-21            | 无                                  | 年龄，教育水平      |
| Ritter et al., 2021            | 病例对照 | MDD HC                       | 27/12 27/12       | 33.5±11.3 32.5±11.2                                     | MRI (PWI)    | DSM-IV-TR SCID HAMD-17 BDI MADRS | 无                                  | 年龄，教育水平，性别   |
| Soriano-Mas et al., 2011       | 队列研究 | MDD HC                       | 30/17 30/17       | 39.1±13.2 39.8±13.0                                     | MRI          | DSM-IV SCID HAMD-17              | 抗抑郁药                               | 年龄，性别        |
| Talishinsky et al., 2022       | 病例对照 | TRD HC                       | 21/10 18/11       | 35.7±9.1 31.7±6.1                                       | fMRI         | HAMD-17                          | 抗抑郁药                               | 年龄，性别，用手习惯   |
| Ugwu et al., 2015              | 病例对照 | MDD HC                       | 35/13 41/14       | 31.0±11.0 28.5±11.0                                     | DTI          | DSM-IV-TR HAMD-17 MADRS BDI      | 抗抑郁药                               | 年龄，教育        |
| Yang et al., 2017              | 病例对照 | MDD HC                       | 58/68 38/54       | MDD: 25.8±5.9 HC: 24.5±6.0                              | MRI          | DSM-IV-TR HAMD-17                | 无                                  | 年龄，性别，教育     |
| Yao et al., 2014               | 病例对照 | MDD HC                       | 45/45 45/45       | 33.3±11.5 34.0±12.4                                     | fMRI         | DSM-IV-TR HAMD-17                | 无                                  | 年龄，教育，性别     |
| Young et al., 2017             | 病例对照 | MDD HC                       | 42/42 42/42       | 18.9±1.3 19.4±1.3                                       | fMRI         | DSM-IV-TR SCID                   | 无                                  | 年龄，教育，性别     |





# 抑郁症患病率性别差异

Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms
https://doi.org/10.1037%2Fbul0000102

# 抑郁症临床性别差异

Sex differences in depression: Insights from clinical and preclinical studies
https://doi.org/10.1016%2Fj.pneurobio.2019.01.006

# sMRI 研究


华西医院：

Sex differences in the clinical characteristics and brain gray matter volume alterations in unmedicated patients with major depressive disorder
https://doi.org/10.1038/s41598-017-02828-4

Sex-specific alterations of cortical morphometry in treatment-naïve patients with major depressive disorder
https://doi.org/10.1038/s41386-021-01252-7

Sex differences of brain cortical structure in major depressive disorder
https://doi.org/10.1093/psyrad/kkad014

Common and sex-specific differences in hypothalamic subunit volumes and their links with depressive symptoms in treatment-naïve patients with major depressive disorder
https://doi.org/10.1007/s00429-025-02904-w

# fMRI 研究

Large-Scale Network Dysfunction in Major Depressive Disorder-A Meta-analysis of Resting-State Functional Connectivity
https://doi.org/10.1001/jamapsychiatry.2015.0071

Sex-specific resting state brain network dynamics in patients with major depressive disorder
https://doi.org/10.1038/s41386-024-01799-1

Study of Sex Differences in Unmedicated Patients With Major Depressive Disorder by Using Resting State Brain Functional Magnetic Resonance Imaging
https://doi.org/10.3389/fnins.2022.814410

Functional neuroimaging highlights sex as a critical variable in depression research
https://doi.org/10.1038/s44220-025-00477-5

# DTI 研究

White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group
https://doi.org/10.1038/s41380-019-0477-2

